ニフェカラント
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2014/08/26 16:47:15」(JST)
[Wiki en表示]
Nifekalant
|
Systematic (IUPAC) name |
6-[(2-{(2-hydroxyethyl)[3-(4-nitrophenyl)propyl]amino}ethyl)amino]-1,3-dimethylpyrimidine-2,4(1H,3H)-dione |
Clinical data |
AHFS/Drugs.com |
International Drug Names |
Legal status |
℞ Prescription only |
Routes |
IV |
Identifiers |
CAS number |
130636-43-0 Y |
ATC code |
None |
PubChem |
CID 4486 |
UNII |
5VZ7GZM43E Y |
Chemical data |
Formula |
C19H27N5O5 |
Mol. mass |
405.44 g/mol |
SMILES
- CN1C(=CC(=O)N(C1=O)C)NCCN(CCCC2=CC=C(C=C2)[N+](=O)[O-])CCO
|
Y (what is this?) (verify) |
Nifekalant (INN) is a class III antiarrhythmic agent approved in Japan for the treatment of arrhythmias and ventricular tachycardia.[1] It has the brand name Shinbit.
References
- ^ Oyabe A, Sano H (February 2002). "[Pharmacological and clinical profile of nifekalant (shinbit injection), a class III antiarrhythmic drug]" ([dead link] – Scholar search). Nippon Yakurigaku Zasshi (in Japanese) 119 (2): 103–9. doi:10.1254/fpj.119.103. PMID 11862758.
Antiarrhythmic agents (C01B)
|
|
Channel blockers |
class I
(Na+ channel blockers)
|
class Ia (Phase 0→ and Phase 3→)
|
- Ajmaline
- Disopyramide
- Lorajmine
- Prajmaline
- Procainamide#
- Quinidine#
- Sparteine
|
|
class Ib (Phase 3←)
|
- IV (Lidocaine#)
- enteral (Aprindine
- Mexiletine
- Tocainide)
|
|
class Ic (Phase 0→)
|
- Encainide‡
- Ethacizine
- Flecainide
- Indecainide‡
- Lorcainide
- Moracizine‡
- Propafenone
|
|
|
class III
(Phase 3→, K+ channel blockers)
|
- Amiodarone
- Bretylium
- Bunaftine
- Dofetilide
- Dronedarone
- E-4031†
- Ibutilide
- Nifekalant
- Sotalol
- Tedisamil
- Vernakalant
|
|
class IV
(Phase 4→, Ca2+ channel blockers)
|
|
|
|
Receptor agonists
and antagonists |
class II
(Phase 4→, β blockers)
|
- Nadolol
- Pindolol
- Propranolol
- cardioselective (Acebutolol
- Atenolol
- Esmolol
- Metoprolol)
|
|
A1 agonist
|
- Adenosine
- Benzodiazepines
- Barbiturates
|
|
M2
|
- muscarinic antagonist: Atropine
- Disopyramide
- Quinidine
muscarinic agonist: Digoxin
|
|
α receptors
|
- Amiodarone
- Bretylium
- Quinidine
- Verapamil
|
|
|
Ion transporters |
|
|
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
|
|
|
|
noco/cong/tumr, sysi/epon, injr
|
proc, drug (C1A/1B/1C/1D), blte
|
|
|
|
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Usefulness of ablation of complex fractionated atrial electrograms using nifekalant in persistent atrial fibrillation.
- Kumagai K, Toyama H.SourceHeart Rhythm Center, Fukuoka Sanno Hospital, Fukuoka, Japan. Electronic address: kumagai@kouhoukai.or.jp.
- Journal of cardiology.J Cardiol.2013 Jan;61(1):44-8. doi: 10.1016/j.jjcc.2012.08.015. Epub 2012 Oct 22.
- BACKGROUND: Additional ablation of complex fractionated atrial electrograms (CFAE) after pulmonary vein isolation (PVI) has been shown to improve the success of ablation of persistent atrial fibrillation (AF). However, extensive ablation is often necessary to eliminate all CFAE or to terminate AF. W
- PMID 23088936
- Development of a reentrant arrhythmia model in human pluripotent stem cell-derived cardiac cell sheets.
- Kadota S, Minami I, Morone N, Heuser JE, Agladze K, Nakatsuji N.SourceInstitute for Integrated Cell-Material Sciences (WPI-iCeMS), Kyoto University, iCeMS Research Building, Yoshida Honmachi, Sakyo-ku, Kyoto 606-8501, Japan.
- European heart journal.Eur Heart J.2012 Nov 30. [Epub ahead of print]
- AimsDevelopment of a human cell-derived reentrant arrhythmia model is needed for studying the mechanisms of disease and accurate drug response.Methods and resultsWe differentiated human pluripotent stem cells (hPSCs) into cardiomyocytes, and then re-plated them into cell sheets that proved capable o
- PMID 23201623
Japanese Journal
- Effects of pH on Nifekalant-Induced Electrophysiological Change Assessed in the Langendorff Heart Model of Guinea Pigs
- Kazusa Katsuyuki,Nakamura Yuji,Watanabe Yudai [他]
- Journal of pharmacological sciences 124(2), 153-159, 2014-02
- NAID 40019992563
- 人工心肺離脱時の難治性心室頻拍(VT ストーム)に対しニフェカラントが著効した症例
- 松川 志乃,石井 久成,福田 和彦
- Cardiovascular Anesthesia 18(1), 25-28, 2014
- 心室頻拍(VT)を頻発する狭心症に対し緊急冠動脈バイパスならびに僧帽弁形成術を施行された症例の麻酔を経験した。アミオダロンを投与中であったが,人工心肺(CPB)離脱中に再度 VT となった。頻回の電気的除細動を行ったが回復せず,難治性心室頻拍(VT ストーム)となり,CPB 離脱困難となった。ニフェカラントの投与により,一時的に心静止しその後洞調律に復帰した。心房ペーシングを行い,安定した循環動 …
- NAID 130004701455
- Effects of pH on Nifekalant-Induced Electrophysiological Change Assessed in the Langendorff Heart Model of Guinea Pigs
- Kazusa Katsuyuki,Nakamura Yuji,Watanabe Yudai,Ando Kentaro,Sugiyama Atsushi
- Journal of Pharmacological Sciences 124(2), 153-159, 2014
- … Since information regarding the effects of pH on the extent of nifekalant-induced repolarization delay and torsades de pointes remains limited, we assessed it with a Langendorff heart model of guinea pigs. …
- NAID 130003391474
Related Links
- ChemicalBook あなたのためにNifekalant(130636-43-0)の化学的性質を提供して、融点、価格、蒸気圧、沸点、毒性、比重、沸点、密度、分子式、分子量、物理的な性質、毒性 税関のコードなどの情報、同時にあなたは更にNifekalant ...
- NIFEKALANT IN ACS PATIENTS Life-threatening ventricular tachyarrhythmias such as VT or VF are likely to develop during the acute phase of ACS, and the occurrence of these arrhythmias has important effects on the prognosis of ...
Related Pictures
★リンクテーブル★
[★]
- 英
- nifekalant
- 同
- 塩酸ニフェカラント nifekalant hydrochloride
- 商
- シンビット
- 関
- 抗不整脈薬、薬理学
- 抗不整脈薬
- クラスIII(選択的カリウムチャネル遮断薬)
[★]
ニフェカラント。塩酸ニフェカラント